Arcadia Biosciences, Inc.
RKDA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $8,071 | $3,872 | $6,497 | $22,132 |
| - Cash | $4,242 | $6,518 | $20,644 | $28,685 |
| + Debt | $155 | $1,007 | $2,017 | $3,294 |
| Enterprise Value | $3,984 | -$1,639 | -$12,130 | -$3,259 |
| Revenue | $5,045 | $4,454 | $7,418 | $6,780 |
| % Growth | 13.3% | -40% | 9.4% | – |
| Gross Profit | $2,082 | $2,280 | $1,317 | -$1,928 |
| % Margin | 41.3% | 51.2% | 17.8% | -28.4% |
| EBITDA | -$7,499 | -$5,731 | -$14,749 | -$27,710 |
| % Margin | -148.6% | -128.7% | -198.8% | -408.7% |
| Net Income | -$7,038 | -$13,981 | -$15,376 | -$14,660 |
| % Margin | -139.5% | -313.9% | -207.3% | -216.2% |
| EPS Diluted | -5.16 | -11.3 | -26.05 | -30.33 |
| % Growth | 54.3% | 56.6% | 14.1% | – |
| Operating Cash Flow | -$9,627 | -$15,294 | -$13,977 | -$25,868 |
| Capital Expenditures | -$16 | -$5 | -$72 | -$1,007 |
| Free Cash Flow | -$9,643 | -$15,299 | -$14,049 | -$26,875 |